Derinide 400 Respicap 30 Capsules

Babies: Not applicable. Lactating mother: Derinide tablet is safe if prescribed by your doctor during breastfeeding. Human studies have shown that this drug may not pass into breast milk and does not harm the baby. Pregnancy: Derinide tablet is not safe to use during pregnancy.
Limited human and animal studies have suggested that this drug may have harmful effects on the developing baby. Consult your doctor. Alcohol: It is unsafe to consume alcohol with derinide. Driving: It is safe to drive after taking this medication and it does not affect your ability to drive. Kidney: Derinide tablet safe to use if prescribed by your doctor in patients with kidney disease.
Dose adjustment is not required. Consult your doctor. Liver: Derinide tablet must be used with caution in patients with liver disease.
Dose adjustment is required. Consult your doctor.
This medication is not prescribed in patients with severe liver disease..

Headache Respiratory infection Nausea Back pain Dizziness Indigestion Flatulence.

Derinide tablet belongs to steroids. It works by blocking the production of certain chemical messengers that cause the inner surface of the large intestine where it becomes ulcerated and inflamed (swollen), resulting in pain..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Derinide tablet is used in the treatment of moderate to severe ulcerative colitis. • Grapefruit must be avoided while taking this medication. • It can be taken with or without food, but take at a fixed time. • Advise the patient to go for bone density and eye tests while taking this medication..

Contraindications: • Derinide + Desmopressin: Concurrent use may result in an increased risk of severe hyponatremia • Derinide + Rotavirus vaccine, live: Concurrent use may result in an increased risk of infection by the liver vaccine Major: • Derinide + Aceclofenac: Concurrent use may result in an increased risk of a gastrointestinal ulcer or bleeding • Derinide + Balofloxacin: Concurrent use may result in an increased risk of tendon rupture • Derinide + Bromofenac: Concurrent use may result in an increased risk of a gastrointestinal ulcer or bleeding • Derinide + Ciprofloxacin: Concurrent use may result in an increased risk of a gastrointestinal ulcer or bleeding • Derinide + Levofloxacin: Concurrent use may result in an increased risk of tendon rupture • Derinide + Mefenamic acid: Concurrent use may result in an increased risk of a gastrointestinal ulcer or bleeding • Derinide + Valdecoxib: Concurrent use may result in an increased risk of a gastrointestinal ulcer or bleeding.